Related Experiment Video
Updated: Dec 12, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Kawasaki syndrome: role of superantigens revisited
Donald Y M Leung1, Patrick M Schlievert2
1Division of Allergy/Immunology, Department of Pediatrics, National Jewish Health, Denver, CO, USA.
Insights
Microbial superantigens may cause Kawasaki syndrome (KS), a childhood vasculitis leading to heart disease. Understanding KS etiology is crucial for developing targeted therapies and improving patient outcomes.
Area of Science:
- Pediatric rheumatology
- Infectious diseases
- Immunology
Background:
- Kawasaki syndrome (KS) is a leading cause of acquired heart disease in children.
- The exact cause of KS remains unknown despite over 50 years of research.
- Current treatments, like intravenous immunoglobulin, are effective but not universally successful.
Purpose of the Study:
- To explore potential etiological factors contributing to Kawasaki syndrome.
- To propose microbial superantigens as a significant trigger for KS.
- To advocate for a deeper understanding of KS pathogenesis for precision medicine.
Main Methods:
- This viewpoint synthesizes existing research on KS etiology and pathogenesis.
- It analyzes the potential role of microbial superantigens in triggering the inflammatory cascade.
- The authors discuss the implications for understanding disease heterogeneity and therapeutic resistance.
Main Results:
- The etiology of coronary artery disease in KS is currently unknown.
- A subset of patients exhibits resistance to standard immunoglobulin therapy.
- KS may represent a cluster of phenotypes influenced by multiple factors.
Conclusions:
- Microbial superantigens are proposed as a key etiological factor in Kawasaki syndrome.
- Further research into superantigen involvement could elucidate KS pathogenesis.
- Identifying the cause of KS is essential for developing precise diagnostic and therapeutic strategies.
Abstract:
Kawasaki syndrome (KS) is an acute vasculitis in children complicated by the development of heart disease. Despite its description over 50 years ago, the etiology of coronary artery disease in KS is unknown. High dose intravenous immunoglobulin is the most effective approach to reduce cardiovascular complications. It remains unclear why patients with KS develop coronary artery aneurysms. A subset of patients is resistant to immunoglobulin therapy. Given the heterogeneity of clinical features, variability of history, and therapeutic response, KS may be a cluster of phenotypes triggered by multiple infectious agents and influenced by various environmental, genetic, and immunologic responses. The cause of KS is unknown, and a diagnostic test remains lacking. A better understanding of mechanisms leading to acute KS would contribute to a more precision medicine approach for this complex disease. In the current viewpoint, we make the case for microbial superantigens as important causes of KS.
More Related Videos
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
13:10In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cross-reactivity
Allergic Drug Reactions
Vaccinations
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Cell-mediated Immune Responses